FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2082911286> ?p ?o ?g. }

• W2082911286 endingPage "94" @default.
• W2082911286 startingPage "89" @default.
• W2082911286 abstract "LDL-apheresis (LDLa) efficacy in the treatment of symptomatic HyperLp(a)lipoproteinemia -HyperLp(a)- has been studied in a multicentre trial. After 3.1±2.7 years of weekly and biweekly treatment, the data from 19 patients (males:12; females:7; aged 53.8±9.3 years; mean body mass index: 24.6±2.3 Kg/m2) were evaluated. Data were collected using the same questionnaire shared by 5 participating centres. A total of 2331 procedures were performed. A mean of 3593.7±800.3 ml of plasma or 8115.3±2150.1 ml of blood, depending upon the technique used (H.E.L.P., D.A.LI., Dextransulphate, Lipocollect 200), was regularly treated on average every 10.1±2.6 days. Baseline mean Lp(a) levels were 172.3±153.8 mg/dL. The mean pre-/post-apheresis Lp(a) levels decreased from 124.5±107.2 mg/dL (p<0.001 vs baseline) to 34.2±40.6 mg/dL (p<0.001 vs pre-). Baseline mean LDL-cholesterol (LDLC) levels were 152.3±74.6 mg/dL. The mean pre-/post-apheresis LDLC levels decreased from 130.4±61.1 mg/dL (p<0.004 vs baseline) to 41.2±25.1 mg/dL (p<0.001 vs pre-). The hypolipidemic drugs given to the patients during LDLa were: ezetimibe+simvastatin, atorvastatin, rosuvastatin, pravastatin, acipimox, and ω-3 fatty acids. 58% of the patients had arterial hypertension. Cigarette smokers were 5.3%. Alcohol intake was present in 21%. 52.6% were physically active. Patients with coronary artery disease (CAD) submitted to coronary catheterization before LDLa were 95%. In 5.5% (#1) CAD recurred despite treatment with LDLa. 79% were submitted to coronary revascularization before LDLa. CAD was: monovasal in 8 patients (42.1%), bivasal in 5 (26.4%), trivasal in 4 (21%), plurivasal in 2 (10.5%). In 94.5% of the sample the lesions were stable (< 0% deviation) over 3.1±2.7 years. 37% had both CAD and extra-coronary artery disease. This multicentre study confirmed that long-term treatment with LDLa was at least able to stabilize CAD in the majority of the individuals with symptomatic HyperLp(a)." @default.
• W2082911286 created "2016-06-24" @default.
• W2082911286 creator A5011065242 @default.
• W2082911286 creator A5020941627 @default.
• W2082911286 creator A5032486927 @default.
• W2082911286 creator A5045899347 @default.
• W2082911286 creator A5053800269 @default.
• W2082911286 creator A5054501484 @default.
• W2082911286 creator A5067875893 @default.
• W2082911286 creator A5083391516 @default.
• W2082911286 creator A5086285478 @default.
• W2082911286 date "2009-12-01" @default.
• W2082911286 modified "2023-10-01" @default.
• W2082911286 title "Treatment of symptomatic HyperLp(a)lipoproteinemia with LDL-apheresis: a multicentre study" @default.
• W2082911286 cites W1979136434 @default.
• W2082911286 cites W1979948203 @default.
• W2082911286 cites W1980975597 @default.
• W2082911286 cites W1983260286 @default.
• W2082911286 cites W1990204315 @default.
• W2082911286 cites W1990884632 @default.
• W2082911286 cites W1991899835 @default.
• W2082911286 cites W1994213302 @default.
• W2082911286 cites W1998239323 @default.
• W2082911286 cites W2006419104 @default.
• W2082911286 cites W2012098057 @default.
• W2082911286 cites W2012268113 @default.
• W2082911286 cites W2016481612 @default.
• W2082911286 cites W2022756739 @default.
• W2082911286 cites W2025221620 @default.
• W2082911286 cites W2031781149 @default.
• W2082911286 cites W2051746391 @default.
• W2082911286 cites W2051873502 @default.
• W2082911286 cites W2085189052 @default.
• W2082911286 cites W2104355263 @default.
• W2082911286 cites W2108284872 @default.
• W2082911286 cites W2117842968 @default.
• W2082911286 cites W2130483103 @default.
• W2082911286 cites W2133778284 @default.
• W2082911286 cites W2146300034 @default.
• W2082911286 doi "https://doi.org/10.1016/s1567-5688(09)71819-7" @default.
• W2082911286 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20129383" @default.
• W2082911286 hasPublicationYear "2009" @default.
• W2082911286 type Work @default.
• W2082911286 sameAs 2082911286 @default.
• W2082911286 citedByCount "19" @default.
• W2082911286 countsByYear W20829112862013 @default.
• W2082911286 countsByYear W20829112862014 @default.
• W2082911286 countsByYear W20829112862015 @default.
• W2082911286 countsByYear W20829112862016 @default.
• W2082911286 countsByYear W20829112862019 @default.
• W2082911286 countsByYear W20829112862022 @default.
• W2082911286 countsByYear W20829112862023 @default.
• W2082911286 crossrefType "journal-article" @default.
• W2082911286 hasAuthorship W2082911286A5011065242 @default.
• W2082911286 hasAuthorship W2082911286A5020941627 @default.
• W2082911286 hasAuthorship W2082911286A5032486927 @default.
• W2082911286 hasAuthorship W2082911286A5045899347 @default.
• W2082911286 hasAuthorship W2082911286A5053800269 @default.
• W2082911286 hasAuthorship W2082911286A5054501484 @default.
• W2082911286 hasAuthorship W2082911286A5067875893 @default.
• W2082911286 hasAuthorship W2082911286A5083391516 @default.
• W2082911286 hasAuthorship W2082911286A5086285478 @default.
• W2082911286 hasConcept C126322002 @default.
• W2082911286 hasConcept C126894567 @default.
• W2082911286 hasConcept C2776738589 @default.
• W2082911286 hasConcept C2777482532 @default.
• W2082911286 hasConcept C2778163477 @default.
• W2082911286 hasConcept C2778657065 @default.
• W2082911286 hasConcept C2778751355 @default.
• W2082911286 hasConcept C2779519902 @default.
• W2082911286 hasConcept C2780499067 @default.
• W2082911286 hasConcept C3019550498 @default.
• W2082911286 hasConcept C71924100 @default.
• W2082911286 hasConcept C89560881 @default.
• W2082911286 hasConcept C90924648 @default.
• W2082911286 hasConceptScore W2082911286C126322002 @default.
• W2082911286 hasConceptScore W2082911286C126894567 @default.
• W2082911286 hasConceptScore W2082911286C2776738589 @default.
• W2082911286 hasConceptScore W2082911286C2777482532 @default.
• W2082911286 hasConceptScore W2082911286C2778163477 @default.
• W2082911286 hasConceptScore W2082911286C2778657065 @default.
• W2082911286 hasConceptScore W2082911286C2778751355 @default.
• W2082911286 hasConceptScore W2082911286C2779519902 @default.
• W2082911286 hasConceptScore W2082911286C2780499067 @default.
• W2082911286 hasConceptScore W2082911286C3019550498 @default.
• W2082911286 hasConceptScore W2082911286C71924100 @default.
• W2082911286 hasConceptScore W2082911286C89560881 @default.
• W2082911286 hasConceptScore W2082911286C90924648 @default.
• W2082911286 hasIssue "5" @default.
• W2082911286 hasLocation W20829112861 @default.
• W2082911286 hasLocation W20829112862 @default.
• W2082911286 hasOpenAccess W2082911286 @default.
• W2082911286 hasPrimaryLocation W20829112861 @default.
• W2082911286 hasRelatedWork W2042179009 @default.
• W2082911286 hasRelatedWork W2051030657 @default.
• W2082911286 hasRelatedWork W2070369222 @default.
• W2082911286 hasRelatedWork W2152065670 @default.
• W2082911286 hasRelatedWork W2164757622 @default.

• next